Hjem › Multipelt myelom › Texas › Tyler
Multipelt myelom kliniske forsøg i Tyler, TX
4 studier for Multipelt myelom søger deltagere på steder i og omkring Tyler (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
A Study to Assess A Change in Disease Activity and Adverse Events of Intravenous Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Adult Participants With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant
RekruttererFase 2/3
- Texas Oncology - Northeast Texas /ID# 278725, Tyler
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
RekruttererFase 1
- Texas Oncology - Northeast Texas /ID# 268877, Tyler
A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
RekruttererFase 3
- GSK Investigational Site, Tyler
Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma
RekruttererFase 2
- Texas Oncology - Northeast Texas, Tyler
Multipelt myelom forsøg i andre byer
- New York City, NY60 studier
- Boston, MA42 studier
- Atlanta, GA41 studier
- Houston, TX38 studier
- Durham, NC37 studier
- Nashville, TN32 studier
- Denver, CO27 studier
- Rochester, MN24 studier
- St. Louis, MO24 studier
- Columbus, OH24 studier
- Baldwin Park, CA23 studier
- Chicago, IL22 studier
Andre studier i Tyler
- Ikke-småcellet lungecancer20 studier
- Crohns sygdom16 studier
- Ulcerøs colitis14 studier
- Colorektal kræft8 studier
- Hjertesvigt8 studier
- Kræft (alle typer)7 studier
- Ægstockræft7 studier
- Livmoderslimhindekræft6 studier
- Pladecellekræft i hoved og hals6 studier
- Brystkræft6 studier
- Metastatisk cancer5 studier
- Inflammatorisk tarmsygdom5 studier
Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.